{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:23:36Z","timestamp":1791426216231,"version":"4.3.3"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00c3\u00a7\u00c3\u00a3o de Aperfei\u00c3\u00a7oamento de Pessoal de N\u00c3\u00advel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00c3\u00a7\u00c3\u00a3o de Aperfei\u00c3\u00a7oamento de Pessoal de N\u00c3\u00advel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bone.2020.115583","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T12:42:53Z","timestamp":1597149773000},"page":"115583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Impaired physical function and evaluation of quality of life in normocalcemic and hypercalcemic primary hyperparathyroidism"],"prefix":"10.1016","volume":"141","author":[{"given":"Lara","family":"Voss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"Griz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Augusto Sampaio","family":"Rocha-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115583_bb0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2020.115583_bb0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1634\/theoncologist.2014-0084","article-title":"Mild primary hyperparathyroidism: a literature review","volume":"19","author":"Applewhite","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.bone.2020.115583_bb0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jamda.2013.08.015","article-title":"Prevalence of sarcopenia in community-dwelling Japanese older adults","volume":"14","author":"Yamada","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.bone.2020.115583_bb0020","first-page":"179","article-title":"Clinical spectrum of primary hyperparathyroidism","volume":"24","author":"Younes","year":"2003","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.bone.2020.115583_bb0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","article-title":"Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?","volume":"55","author":"Marques","year":"2011","journal-title":"Arq Bras Endocrinol. Metabol."},{"key":"10.1016\/j.bone.2020.115583_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-15-0030","article-title":"Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy","volume":"4","author":"Vignali","year":"2015","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.bone.2020.115583_bb0035","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115583_bb0040","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","article-title":"Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations","volume":"98","author":"Cusano","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2020.115583_bb0045","first-page":"N18","article-title":"Epidemiology of primary hyperparathyroidism in Europe","volume":"17","author":"Adami","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115583_bb0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.beem.2018.09.004","article-title":"Primary hyperparathyroidism","volume":"32","author":"Silva","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115583_bb0055","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115583_bb0060","doi-asserted-by":"crossref","first-page":"E1465","DOI":"10.1152\/ajpendo.00487.2006","article-title":"Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism","volume":"292","author":"Reppe","year":"2007","journal-title":"AJP Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115583_bb0065","doi-asserted-by":"crossref","first-page":"F665","DOI":"10.1152\/ajprenal.1999.277.5.F665","article-title":"Receptors for PTH and PTHrP: their biological importance and functional properties","volume":"277","author":"Mannstadt","year":"1999","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.bone.2020.115583_bb0070","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1038\/srep05066","article-title":"Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation","volume":"4","author":"Kimura","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2020.115583_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1015716726452","article-title":"Molecular cloning and functional characterization of the canine parathyroid hormone\/parathyroid hormone related peptide receptor (PTH1)","volume":"28","author":"Smock","year":"2001","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bone.2020.115583_bb0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9343(89)80613-8","article-title":"Neuromuscular involvement in mild, assyntomatic primary hyperparathyroidism","volume":"87","author":"Turken","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2020.115583_bb0085","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1532-5415.1999.tb05199.x","article-title":"Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel","volume":"47","author":"Stein","year":"1999","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bone.2020.115583_bb0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00268-013-2273-5","article-title":"Muscle function is impaired in patients with \u201casymptomatic\u201d primary hyperparathyroidism","volume":"38","author":"Rolighed","year":"2014","journal-title":"World J. Surg."},{"key":"10.1016\/j.bone.2020.115583_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/2013.jamasurg.316","article-title":"Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study","volume":"148","author":"Weber","year":"2013","journal-title":"JAMA Surg."},{"key":"10.1016\/j.bone.2020.115583_bb0100","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-014-3731-5","article-title":"Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study","volume":"21","author":"Blanchard","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bone.2020.115583_bb0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0039-6060(96)80048-1","article-title":"Assessment of patient outcomes after operation for primary hyperparathyroidism","volume":"120","author":"Burney","year":"1996","journal-title":"Surgery"},{"key":"10.1016\/j.bone.2020.115583_bb0110","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115583_bb0115","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115583_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1532-5415.2008.02126.x","article-title":"Added value of physical performance measures in predicting adverse health-related events: results from the health, aging, and body composition study setting-health, aging, and body composition study","volume":"57","author":"Cesari","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bone.2020.115583_bb0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.bone.2020.115583_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0763-7","article-title":"Short physical performance battery and all-cause mortality: systematic review and meta-analysis","volume":"14","author":"Pavasini","year":"2016","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.bone.2020.115583_bb0135","first-page":"143","article-title":"Tradu\u00e7\u00e3o para a lingua portuguesa e valida\u00e7\u00e3o do question\u00e1rio gen\u00e9rico de avalia\u00e7\u00e3o de qualidade de vida SF-36 (Brasil SF-36)","volume":"39","author":"Ciconelli","year":"1999","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/j.bone.2020.115583_bb0140","first-page":"5","article-title":"International physical activity questionnaire (IPAQ): study of validity and reliability in Brazil","volume":"6","author":"Matsudo","year":"2001","journal-title":"Rev Bras Atividade F\u00edsica Sa\u00fade"},{"key":"10.1016\/j.bone.2020.115583_bb0145","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1532-5415.2008.01854.x","article-title":"Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan","volume":"56","author":"Chien","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"issue":"A","key":"10.1016\/j.bone.2020.115583_bb0150","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bone.2020.115583_bb0155","first-page":"1","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","author":"Cruz-Jentoft","year":"2018","journal-title":"Age Ageing"},{"key":"10.1016\/j.bone.2020.115583_bb0160","doi-asserted-by":"crossref","first-page":"775.e5","DOI":"10.1016\/j.jamda.2013.06.013","article-title":"New normative values for handgrip strength: results from the uk biobank","volume":"14","author":"Spruit","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.bone.2020.115583_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0113637","article-title":"Grip strength across the life course: normative data from twelve British studies","volume":"9","author":"Dodds","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115583_bb0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2519\/jospt.2018.7851","article-title":"Hand-grip strength: normative reference values and equations for individuals 18 to 85\u00a0years of age residing in the United States","volume":"48","author":"Wang","year":"2018","journal-title":"J. Orthop. Sports Phys. Ther."},{"key":"10.1016\/j.bone.2020.115583_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14310\/horm.2002.1225","article-title":"Medical treatment of hypercalcaemia","volume":"8","author":"Makras","year":"2009","journal-title":"Hormones"},{"key":"10.1016\/j.bone.2020.115583_bb0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/110241598750005822","article-title":"Muscle strength and endurance after surgery for primary hyperparathyroidism. 1","volume":"164","author":"Colliander","year":"1998","journal-title":"Eur. J. Su"},{"key":"10.1016\/j.bone.2020.115583_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0039-6060(05)80224-7","article-title":"Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism","volume":"117","author":"Chou","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.bone.2020.115583_bb0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00000658-199509000-00017","article-title":"Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study","volume":"222","author":"Chan","year":"1995","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bone.2020.115583_bb0195","first-page":"521","article-title":"Improvement of muscle strength after treatment for hyperparathyroidism","volume":"150","author":"Hedman","year":"1984","journal-title":"Acta Chir. Scand."},{"key":"10.1016\/j.bone.2020.115583_bb0200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002689910019","article-title":"Muscular performance and fatigue in primary hyperparathyroidism","volume":"24","author":"Deutch","year":"2000","journal-title":"World J. Surg."},{"key":"10.1016\/j.bone.2020.115583_bb0205","first-page":"13","article-title":"Muscle structure and function before and after surgery for primary hyperparathyroidism","volume":"157","author":"Jansson","year":"1991","journal-title":"Eur. J. Surg."},{"key":"10.1016\/j.bone.2020.115583_bb0210","unstructured":"Kristoffersson A, Bjerle P, Stjernberg N, J\u00e4rhult J. Pre- and postoperative respiratory muscle strength in primary hyperparathyroidism. Acta Chir. Scand. n.d.;154:415\u20138."},{"key":"10.1016\/j.bone.2020.115583_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0954-6820.1986.tb02756.x","article-title":"Increase in muscular strength following surgery for primary hyperparathyroidism","volume":"220","author":"Wers\u00e4ll-Robertson","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.bone.2020.115583_bb0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5694\/j.1326-5377.1988.tb120508.x","article-title":"Neuromuscular symptoms in elderly patients with hyperparathyroidism: improvement with parathyroid surgery","volume":"149","author":"Delbridge","year":"1988","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bone.2020.115583_bb0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bjs.1800750128","article-title":"Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery","volume":"75","author":"Joborn","year":"1988","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.bone.2020.115583_bb0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/bjs.1800790223","article-title":"Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism","volume":"79","author":"Kristoffersson","year":"1992","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.bone.2020.115583_bb0235","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2265.2010.03906.x","article-title":"Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study","volume":"74","author":"Amstrup","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2020.115583_bb0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1152\/physrev.1977.57.3.421","article-title":"Relationships between calcium and cyclic nucleotides in cell activation","volume":"57","author":"Rasmussen","year":"1977","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2020.115583_bb0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4158\/EP12207.OR","article-title":"Primary hyperparathyroidism is associated with subclinical peripheral neural alterations","volume":"19","author":"Diniz","year":"2013","journal-title":"Endocr. Pr."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822030363X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822030363X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:49:29Z","timestamp":1757612969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822030363X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":49,"alternative-id":["S875632822030363X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115583","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired physical function and evaluation of quality of life in normocalcemic and hypercalcemic primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115583"}}